Pfizer(NYSE: PFE) announced earnings per share of $1.08 before the bell on Tuesday, with revenue coming in at $23.84 billion.
The numbers reported were against an anticipated EPS of $0.88 and revenue of $24.17 billion. The company’s revenue miss can be attributed to internal medicine sales falling 3% year-over-year to $2.24 billion, while hospital sales were little moved at $1.88 billion.
In reaction to the report, Pfizer’s share price has declined 3.7% premarket to $51.24.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Pfizer said it expects to generate record-high revenue in 2022, forecasting $32 billion in sales of its Covid-19 vaccine and $22 billion of its antiviral coronavirus treatment pill Paxlovid. Overall, Pfizer expects between $98 billion and $102 billion in sales for 2022, with adjusted earnings per share coming in between $6.35 to $6.55.
Frank D’Amelio, Chief Financial Officer and Executive Vice President of Pfizer said, “the company is performing better than at any other time during my nearly 15 years here. Today we are issuing guidance for the coming year which, if achieved, would represent the highest level of annual revenues and Adjusted diluted EPS in Pfizer’s long history.”
